184 related articles for article (PubMed ID: 15126331)
21. Low incidence of methylation of the promoter region of the FANCF gene in Japanese primary breast cancer.
Tokunaga E; Okada S; Kitao H; Shiotani S; Saeki H; Endo K; Morita M; Kakeji Y; Maehara Y
Breast Cancer; 2011 Apr; 18(2):120-3. PubMed ID: 19813073
[TBL] [Abstract][Full Text] [Related]
22. Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway.
Medhurst AL; Huber PA; Waisfisz Q; de Winter JP; Mathew CG
Hum Mol Genet; 2001 Feb; 10(4):423-9. PubMed ID: 11157805
[TBL] [Abstract][Full Text] [Related]
23. Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors.
Koul S; McKiernan JM; Narayan G; Houldsworth J; Bacik J; Dobrzynski DL; Assaad AM; Mansukhani M; Reuter VE; Bosl GJ; Chaganti RS; Murty VV
Mol Cancer; 2004 May; 3():16. PubMed ID: 15149548
[TBL] [Abstract][Full Text] [Related]
24. Pyrosequencing-based DNA methylation profiling of Fanconi anemia/BRCA pathway genes in laryngeal squamous cell carcinoma.
Szaumkessel M; Richter J; Giefing M; Jarmuz M; Kiwerska K; Tönnies H; Grenman R; Heidemann S; Szyfter K; Siebert R
Int J Oncol; 2011 Aug; 39(2):505-14. PubMed ID: 21567085
[TBL] [Abstract][Full Text] [Related]
25. RNA interferences targeting the Fanconi anemia/BRCA pathway upstream genes reverse cisplatin resistance in drug-resistant lung cancer cells.
Dai CH; Li J; Chen P; Jiang HG; Wu M; Chen YC
J Biomed Sci; 2015 Sep; 22(1):77. PubMed ID: 26385482
[TBL] [Abstract][Full Text] [Related]
26. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.
Garcia-Higuera I; Taniguchi T; Ganesan S; Meyn MS; Timmers C; Hejna J; Grompe M; D'Andrea AD
Mol Cell; 2001 Feb; 7(2):249-62. PubMed ID: 11239454
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
[TBL] [Abstract][Full Text] [Related]
28. The FA/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells.
Chen Q; Van der Sluis PC; Boulware D; Hazlehurst LA; Dalton WS
Blood; 2005 Jul; 106(2):698-705. PubMed ID: 15802532
[TBL] [Abstract][Full Text] [Related]
29. CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin.
Dhillon VS; Shahid M; Husain SA
Mol Cancer; 2004 Dec; 3():33. PubMed ID: 15574200
[TBL] [Abstract][Full Text] [Related]
30. Promoter hypermethylation of SOX11 promotes the progression of cervical cancer in vitro and in vivo.
Li X; Wu X; Li Y; Cui Y; Tian R; Singh N; Ding M; Yang Y; Gao Y
Oncol Rep; 2019 Apr; 41(4):2351-2360. PubMed ID: 30720133
[TBL] [Abstract][Full Text] [Related]
31. Silencing of fanconi anemia complementation group f exhibits potent chemosensitization of mitomycin C activity in breast cancer cells.
Yu J; Zhao L; Li Y; Li N; He M; Bai X; Yu Z; Zheng Z; Mi X; Wang E; Wei M
J Breast Cancer; 2013 Sep; 16(3):291-9. PubMed ID: 24155758
[TBL] [Abstract][Full Text] [Related]
32. Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer.
Lim SL; Smith P; Syed N; Coens C; Wong H; van der Burg M; Szlosarek P; Crook T; Green JA
Br J Cancer; 2008 Apr; 98(8):1452-6. PubMed ID: 18414472
[TBL] [Abstract][Full Text] [Related]
33. Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer.
Zhang Z; Huettner PC; Nguyen L; Bidder M; Funk MC; Li J; Rader JS
Oncogene; 2006 Aug; 25(39):5436-45. PubMed ID: 16607278
[TBL] [Abstract][Full Text] [Related]
34. Promoter Hypermethylation of FANCF and Susceptibility and Prognosis of Epithelial Ovarian Cancer.
Ding JJ; Wang G; Shi WX; Zhou HH; Zhao EF
Reprod Sci; 2016 Jan; 23(1):24-30. PubMed ID: 26507869
[TBL] [Abstract][Full Text] [Related]
35. Molecular pathogenesis of fanconi anemia.
Taniguchi T; Dandrea AD
Int J Hematol; 2002 Feb; 75(2):123-8. PubMed ID: 11939257
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma.
Wreesmann VB; Estilo C; Eisele DW; Singh B; Wang SJ
ORL J Otorhinolaryngol Relat Spec; 2007; 69(4):218-25. PubMed ID: 17409780
[TBL] [Abstract][Full Text] [Related]
37. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
[TBL] [Abstract][Full Text] [Related]
38. RNF4-mediated polyubiquitination regulates the Fanconi anemia/BRCA pathway.
Xie J; Kim H; Moreau LA; Puhalla S; Garber J; Al Abo M; Takeda S; D'Andrea AD
J Clin Invest; 2015 Apr; 125(4):1523-32. PubMed ID: 25751062
[TBL] [Abstract][Full Text] [Related]
39. Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome.
Narayan G; Arias-Pulido H; Koul S; Vargas H; Zhang FF; Villella J; Schneider A; Terry MB; Mansukhani M; Murty VV
Mol Cancer; 2003 May; 2():24. PubMed ID: 12773202
[TBL] [Abstract][Full Text] [Related]
40. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.
Xie Y; de Winter JP; Waisfisz Q; Nieuwint AW; Scheper RJ; Arwert F; Hoatlin ME; Ossenkoppele GJ; Schuurhuis GJ; Joenje H
Br J Haematol; 2000 Dec; 111(4):1057-64. PubMed ID: 11167740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
